| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Okt―03 |
The Role of NEU1 in Coronavirus Infection and Pathogenesis |
Chen GY |
| 2 |
[GO] |
2024―Mrz―06 |
Severity and Situation of Asbestosis in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
Cheepsattayakorn A |
| 3 |
[GO] |
2024―Feb―07 |
Origin and Evolution of SARS-CoV-2: An Enigma |
Iqbal J |
| 4 |
[GO] |
2024―Jan―25 |
Machine Learning-Based Sentiment Analysis of Tweets about COVID-19 Vaccines |
Çakıt E |
| 5 |
[GO] |
2024―Jan―25 |
SARS-CoV-2 Orf1ab Genome Mutations, the Driving Force for Virus Pathogenicity |
Cobar O |
| 6 |
[GO] |
2023―Nov―15 |
Era of COVID-19 Pandemic Influencing on Global Tuberculosis Epidemic |
Cheepsattayakorn A |
| 7 |
[GO] |
2023―Okt―02 |
The Molecular Docking and Dynamic Analyses of 3',5-Dihydroxy4',6,7-Trimethoxyflavanone, Isovitexin-2'-O-Rhamnoside, Solafuranone, (R)-5,3'-Dimethyl hesperidin, Phloretin 3',5'-Di-C -glucoside, Isomargaritene, Margaritene and Clemomandshuricoside B for Potential COVID-19 Therapy |
Serap Yalcin |
| 8 |
[GO] |
2023―Okt―02 |
The Power of Viruses The COVID-19-Pandemic: A Harbinger of a Disastrous Geopolitics |
Vogt PR |
| 9 |
[GO] |
2023―Okt―02 |
Aspects of Testing for and Vaccinations against Coronavirus in Germany and Worldwide |
Fabian R |
| 10 |
[GO] |
2023―Sep―21 |
Therapeutic Drug Targets for Covid-19 |
Yalcin S |
| 11 |
[GO] |
2023―Sep―21 |
Targeting Spike Protein: Modified Antibody for Broad-Spectrum Binding to Coronaviruses: An In Silico Study |
Rai RC |
| 12 |
[GO] |
2023―Sep―08 |
Undetermined Implications of Islamic Veil Practicing for COVID-19 Diagnosis and Treatment |
Rastmanesh R |
| 13 |
[GO] |
2023―Sep―08 |
AstraZeneca Covid-19 Vaccine Reaction after a Second Dose Administration: A Case Study in Eldoret, Kenya |
Kwena AVM |
| 14 |
[GO] |
2023―Sep―08 |
Physiotherapy and Cardiopulmonary Rehabilitation Approaches in SARS-CoV-2 Infection |
Artik Y |
| 15 |
[GO] |
2023―Apr―05 |
Monitoring of Immune Response Following Covid-19 Vaccination |
Velasquez Serra GC |
| 16 |
[GO] |
2023―Apr―05 |
Methodological Considerations for Design of Studies Investigating Gender Differences in COVID-19 Mortality |
Rastmanesh R |
| 17 |
[GO] |
2023―Apr―05 |
Evaluation of Antibody Response in COVID-19 Recovered Population of Swat Kp, Pakistan |
Khan I |
| 18 |
[GO] |
2023―Apr―05 |
Rhesus Blood Group C (RH2) is Associated with Protection against SARS-Cov-2 Infections |
Motswaledi MS |
| 19 |
[GO] |
2022―Okt―22 |
Distribution of Dengue Virus Serotypes during the COVID 19 Pandemic in Sri Lanka |
Janaki Abeynayake |
| 20 |
[GO] |
2022―Sep―07 |
Clinical Characteristics and Prognostic Factors of Severity in Covid-19 Patients in Lahore, Pakistan |
Junaid K |
| 21 |
[GO] |
2022―Sep―07 |
Factors Contributing to COVID-19 Vaccine Hesitancy among Taxi Drivers in Juba City-South Sudan |
Jibi MC |
| 22 |
[GO] |
2022―Sep―06 |
Models for the Study of the Effects of COVID-19 on Dermatological Health |
Quintero Soto ML |
| 23 |
[GO] |
2022―Sep―06 |
Structural Insight into Antibody Evasion of SARS-Cov-2 Omicron Variant |
Subbarao N |
| 24 |
[GO] |
2022―Sep―06 |
First and Preliminary Data about Sars-CoV-2 Serology among Asymptomatic Workers in Central African Republic |
Mossoro Kpinde CD |
| 25 |
[GO] |
2022―Sep―05 |
Modelling of Perception Covid-19 |
Garcia Lirios C |
| 26 |
[GO] |
2022―Sep―05 |
Possible Use of Ganoderma Mushroom Extracts for the Treatment of Some Chronic Risk Factors Associated with Severe Covid-19 |
Ohimain EI |
| 27 |
[GO] |
2022―Sep―05 |
Is it Necessary to Trace for and Isolate Asymptomatic COVID-19 (+) Healthcare Workers in a COVID-19 Infected Ward? |
Monastiriotis C |
| 28 |
[GO] |
2022―Sep―05 |
COVID-19, Immune System and Hi-D FACS |
Heydari K |
| 29 |
[GO] |
2022―Sep―05 |
Coronavirus Disease (COVID-19) Infection and Innate ImmunoResponse: Pathway to Eradicating the Pandemic |
Ekom Ndifreke Edem |
| 30 |
[GO] |
2022―Sep―05 |
About Covid-19 Infection in Côte d'Ivoire, West Africa |
YAPO-CREZOIT C |
| 31 |
[GO] |
2022―Sep―05 |
Quantitative COVID-19 Infectiousness Estimate Correlating with Viral Shedding and Culturability Suggests 68% Pre-Symptomatic Transmissions |
Prakash MK |
| 32 |
[GO] |
2022―Sep―05 |
In Silico Study by Quantum MicroRNA Language for the Development of Anti-COVID-19 Agents: COVID-19 Is Prevented by Rice MIR2097-5p through Suppression of SARS-Cov-2 Viral MicroRNAs plus HIPK2 Target Proteins |
Fujii YR |
| 33 |
[GO] |
2022―Sep―05 |
Perception, Attitude and Practice of Personal Protective Measures by Nigerians during the COVID-19 Outbreak: An Online Cross-Sectional Study |
Ugwu MC |
| 34 |
[GO] |
2022―Sep―05 |
Effects of COVID-19 Outbreaks on Livestock Sector |
Singh NK |
| 35 |
[GO] |
2022―Sep―05 |
Covid-19 Pandemic and Its Novel Virus: Lessons Learnt so Far |
Chikere Atulaegwu Anusiem |
| 36 |
[GO] |
2022―Sep―05 |
Nanotechnology: An Aid to Human Welfare in COVID-19 Pandemic Era |
Tripathi M |
| 37 |
[GO] |
2022―Sep―05 |
COVID-19 Pandemic: How Prepared is Sub-Sahara Africa to Deal with this Dreadful "Guest "? |
Balogun O |
| 38 |
[GO] |
2022―Sep―05 |
Molecular Analysis of Covid-19 Patient Real Time PCR and their Medicational Clinical Trials |
Muhammad Waqar Mazhar |
| 39 |
[GO] |
2022―Sep―05 |
How Will the Covid-19 Vaccines Help Shape the Herd Immunity against Covid-19? |
Weitao T |
| 40 |
[GO] |
2022―Sep―05 |
The Impact of E-Learning (Distance Learning) Implementation during COVID-19 Virus Pandemic on Intended Learning Outcomes Achievement in Universities |
Shalaby EA |
| 41 |
[GO] |
2022―Sep―05 |
Covid-19: A Hypothetical View on Infection |
Dragan Nikolic M |
| 42 |
[GO] |
2022―Sep―05 |
Could UPR Manipulation Help to Tune the Inflammatory Response in the Course of COVID-19? |
Cirone M |
| 43 |
[GO] |
2022―Sep―05 |
Use of Video/Listening Content Transcripts in English for Coronavirus Awareness and Information |
Saka NE |
| 44 |
[GO] |
2022―Sep―05 |
Could SARS-Cov-2 Establish Persistent Infection in a Certain Population of Infected Individuals |
Ikuta K |
| 45 |
[GO] |
2022―Sep―05 |
HIV and SARS-Cov-2 the Dilemma |
Abreu C |
| 46 |
[GO] |
2022―Sep―05 |
Sars-Cov-2- Infection in Pregnancy |
Syed W |
| 47 |
[GO] |
2022―Jul―11 |
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) by A Third Dose of Chadox1 Ncov-19 (Astrazeneca) After BNT162b2 (Pfizer-BioNTech) |
Costa-Filho RC |
| 48 |
[GO] |
2020―Jul―03 |
SARS-Cov-2: Biology, Detection, Macrophage Mediated Pathogenesis and Potential Treatments |
Loyda M Melendez |
| 49 |
[GO] |
2020―Jul―03 |
SARS-Cov-2: Biology, Detection, Macrophage Mediated Pathogenesis and Potential Treatments |
Melendez LM |
| 50 |
[GO] |
2020―Jun―17 |
The Etiology of COVID-19 in Silico by SARS-Cov-2 Infection with the Quantum MicroRNA Language-AI |
Fujii YR |
